Of further note, activities of aPKC and Akt are strongly/maximally activated by uncertain, presumably noninsulin, factors in brains of humans with nondiabetic AD,69 and these aPKC elevations may increase BACE1 and thereby decrease IRs while simultaneously increasing Aβ‐plaque formation and AD risk. This evidence concerns the gene AKT1 and Alzheimer disease.